You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rivastigmine

Showing 1 - 25 of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Depressive Disorder Trial in Utrecht (Rivastigmine Transdermal Product, Sham)

Recruiting
  • Depressive Disorder
  • Rivastigmine Transdermal Product
  • Sham
  • Utrecht, Netherlands
    UMC Utrecht
Mar 2, 2023

Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)

Active, not recruiting
  • Bioequivalence
  • Rivastigmine twice-weekly 9,5 mg/24 h
  • Exelon® 9.5 mg/24 h
  • Erfurt, Thuringia, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023

Progressive Supranuclear Palsy (PSP) Trial in Marseille Cedex 5 (Rivastigmine, Placebo)

Active, not recruiting
  • Progressive Supranuclear Palsy (PSP)
  • Rivastigmine
  • Placebo
  • Marseille Cedex 5, France
    Service de Neurologie et Pathologie du Mouvement Hôpital de La T
Aug 22, 2022

Bioavailability Trial in Baltimore (Rivastigmine (RLD) transdermal patch, Rivastigmine (generic) transdermal patch)

Completed
Has Results
  • Bioavailability
  • Rivastigmine (RLD) transdermal patch
  • Rivastigmine (generic) transdermal patch
  • Baltimore, Maryland
    General Clinical Research Center (GCRC) at the University of Mar
Apr 1, 2022

Alzheimer's Disease Trial in India (Rivastigmine)

Completed
  • Alzheimer's Disease
  • Rivastigmine
  • Bangalore, Karnataka, India
  • +9 more
Jan 24, 2023

Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)

Recruiting
  • Bioequivalence
  • RID-TDS 13.3 mg/24 h
  • Exelon® 13.3 mg/24 h
  • Erfurt, Thüringen, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023

Nutraceuticals and Drug Treatment in Frail Older Adults

Recruiting
  • Frailty
  • Nutraceuticals
  • Naples, It, Italy
    Pasquale Mone
May 4, 2022

Parkinson Disease, Parkinson Disease Dementia Trial in Baltimore (Rivastigmine transdermal patch)

Completed
  • Parkinson Disease
  • Parkinson Disease Dementia
  • Rivastigmine transdermal patch
  • Baltimore, Maryland
    University of Maryland School of Medicine, Dept. of Neurology
Jan 25, 2022

Alzheimer, CVA (Cerebrovascular Accident) Trial in Singapore (Rivastigmine)

Completed
  • Alzheimer Disease
  • CVA (Cerebrovascular Accident)
  • Rivastigmine
  • Singapore, Singapore
    National Neuroscience Institute
Mar 3, 2021

Hallucinations, Auditory, Psychosis Trial in New Haven (Rivastigmine Transdermal Product, Scopolamine, Placebo)

Recruiting
  • Hallucinations, Auditory
  • Psychosis
  • Rivastigmine Transdermal Product
  • +2 more
  • New Haven, Connecticut
    Connecticut Mental Health Center
Mar 2, 2022

Delirium Trial in Cairo (Rivastigmine Transdermal System [Exelon], Melatonin)

Completed
  • Delirium
  • Rivastigmine Transdermal System [Exelon]
  • Melatonin
  • Cairo, Abassia, Egypt
    Ain Shams University
Jul 8, 2020

Parkinson Disease Trial in United Kingdom (Rivastigmine Transdermal System, Placebo Transdermal System)

Recruiting
  • Parkinson Disease
  • Rivastigmine Transdermal System
  • Placebo Transdermal System
  • Romford, Accepted, United Kingdom
  • +26 more
Dec 22, 2021

Parkinson's Disease Trial in Portland (Strattera, Exelon, Placebo)

Completed
Has Results
  • Parkinson's Disease
  • Portland, Oregon
    Oregon Health & Science University
Jun 17, 2020

Healthy Trial in Oxford (Reboxetine, Rivastigmine, Placebo oral tablet)

Completed
  • Healthy
  • Oxford, Oxfordshire, United Kingdom
    Dept of Psychiatry, University of Oxford
Jun 15, 2020

Bioequivalence Trial in Erfurt (RID-TDS 9.5 mg/24 h, Exelon® 9.5 mg/24 h)

Completed
  • Bioequivalence
  • RID-TDS 9.5 mg/24 h
  • Exelon® 9.5 mg/24 h
  • Erfurt, Thüringen, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
Sep 18, 2019

Mild to Moderate Alzheimer's Disease Trial in Japan (Rivastigmine Patch)

Completed
Has Results
  • Mild to Moderate Alzheimer's Disease
  • Rivastigmine Patch
  • Fukuoka city, Fukuoka, Japan
  • +18 more
Aug 5, 2019

Dementia Trial in Porto (Treatment withdrawal)

Completed
  • Dementia
  • Treatment withdrawal
  • Porto, Portugal
    Centro Hospitalar Universitário de São João
Apr 4, 2022

Alzheimer Trial in Worldwide (Masitinib, Placebo)

Completed
  • Alzheimer Disease
  • Varna, Bulgaria
  • +5 more
Dec 7, 2020

Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)

Not yet recruiting
  • Alzheimer Disease
  • Placebo
  • +2 more
  • Paris, France
    Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
Sep 29, 2022

Dementia, Cognitive Impairment, Mild Cognitive Impairment Trial in Bronx (5-Cog, Health Literacy & Grip Assessment)

Active, not recruiting
  • Dementia
  • +3 more
  • 5-Cog
  • Health Literacy & Grip Assessment
  • Bronx, New York
    Albert Einstein College of Medicine
Dec 21, 2022

Dementia, Dementia, Vascular, Dementia With Lewy Bodies Trial in United States (Care Ecosystem)

Not yet recruiting
  • Dementia
  • +4 more
  • Care Ecosystem
  • San Francisco, California
  • +5 more
Dec 20, 2022

Alzheimer's Disease Trial (Thymatron IV device (Somatics))

Not yet recruiting
  • Alzheimer's Disease
  • Thymatron IV device (Somatics)
  • (no location specified)
Apr 21, 2021

Diabetes in Elderly People With Dementia in France

Completed
  • Alzheimer Disease
  • Incidence analysis
  • Toulouse, France
    University Hospital
Aug 31, 2021

Diabetes, Type 2 Trial in Easton (Donepezil 5-10 Mg Oral Tablet, Placebo Oral Tablet)

Recruiting
  • Diabetes Mellitus, Type 2
  • Donepezil 5-10 Mg Oral Tablet
  • Placebo Oral Tablet
  • Easton, Maryland
    University of Maryland Shore Regional Health
Oct 20, 2021

Alzheimer Trial in Canada (Montelukast buccal film, Placebo buccal film)

Recruiting
  • Alzheimer Disease
  • Montelukast buccal film
  • Placebo buccal film
  • Victoria, British Columbia, Canada
  • +12 more
Jul 21, 2022